
Chitose Bio Evolution
$48.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Chitose Bio Evolution is currently valued at N/A as of March 10, 2025. The company has raised a total of $82.8M in funding.
Investment Perspective
Chitose Bio Evolution's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Chitose Bio Evolution Worth in 2025?
As of 2025, Chitose Bio Evolution is valued at N/A, based on the company's Later Stage VC funding round in March 10, 2025. This valuation positions Chitose Bio Evolution as one of the leading private companies in the sector.
Chitose Bio Evolution Valuation History
Chitose Bio Evolution's funding history demonstrates steady growth and investor confidence.
How Chitose Bio Evolution Valuation is Determined
Private company valuations like Chitose Bio Evolution's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Chitose Bio Evolution Valuation FAQs
Is Chitose Bio Evolution profitable?
Chitose Bio Evolution has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Chitose Bio Evolution's valuation compare to competitors?
Chitose Bio Evolution is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Chitose Bio Evolution IPO?
Chitose Bio Evolution has not announced plans for an initial public offering. Until an IPO, investors can access Chitose Bio Evolution shares through secondary market platforms.